Pfizer head Albert Bourla writing book about Covid vaccine
Pfizer Chairman and CEO Dr. Albert Bourla can now look back and tell the incredible story
Your support helps us to tell the story
As your White House correspondent, I ask the tough questions and seek the answers that matter.
Your support enables me to be in the room, pressing for transparency and accountability. Without your contributions, we wouldn't have the resources to challenge those in power.
Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election
Andrew Feinberg
White House Correspondent
Pfizer Chairman and CEO Dr. Albert Bourla can now tell the incredible story.
Bourla has a deal with Harper Business for what the publisher is calling “an exclusive, first-hand, behind-the-scenes story” of how the drugmaker managed to develop an effective vaccine against COVID-19 in a remarkably short period of time — months instead of years. Bourla's “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible” is scheduled to come out Nov. 9.
“I am sharing the story of our moonshot — the challenges we faced, the lessons we learned, and the core values that allowed us to make it happen — in hopes that it might inspire and inform your own moonshot, whatever that may be," Bourla, 59, said in a statement.
Financial terms were not disclosed. Bourla plans to donate any proceeds to charity.
A native of Greece and descendant of Holocaust survivors, Bourla joined Pfizer in 1993 and rose to CEO in 2018. Pfizer last December became the first U.S. company to have a vaccine authorized by the FDA which days later approved a vaccine by Moderna and in February one by Johnson & Johnson.
On Monday, the FDA approved the Pfizer vaccine for ages 12-15.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.